Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.37x
BAYERCROP's operating cash flow was significantly below net income in FY 2025, suggesting earnings include substantial non-cash items.
Free Cash Flow
₹2.21B
BAYERCROP's free cash flow was ₹2.21B in FY 2025, down 75.6% from FY 2024.
Dividend Coverage
0.4x
BAYERCROP's free cash flow did not fully cover dividends in FY 2025. The company may be funding dividends from reserves or borrowings.
CapEx Intensity
15.6%
Capital expenditure was 15.6% of operating cash flow in FY 2025 for BAYERCROP, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 9.41B | 7.07B | |
| Cash flow Operating Activities | 9.52B | 2.62B | |
| Investments in PPE | -457.00M | -409.00M | |
| Cash flow Investing Activities | 4.00M | 856.00M | |
| Dividend Paid | -6.07B | -5.61B | |
| Cash flow Financing Activities | -6.56B | -6.19B | |
| Cash at beginning of period | 8.61B | 11.57B | |
| Cash at end of period | 11.57B | 8.85B | |
| Free Cash Flow | 9.06B | 2.21B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025